Insider Transactions in Q1 2022 at Kal Vista Pharmaceuticals, Inc. (KALV)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 09
2022
|
Thomas Andrew Crockett CEO |
SELL
Open market or private sale
|
Direct |
10,000
-8.02%
|
$170,000
$17.07 P/Share
|
|
Jan 07
2022
|
Edward P. Feener CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
57,657
+38.44%
|
$403,599
$7.64 P/Share
|